Daxor (NASDAQ:DXR) Price Target Raised to $25.00

Daxor (NASDAQ:DXR) had its target price increased by Ascendiant Capital Markets from $24.75 to $25.00 in a report released on Monday morning,Benzinga reports. Ascendiant Capital Markets currently has a buy rating on the stock.

Daxor Price Performance

Daxor stock opened at $8.27 on Monday. The company’s 50 day moving average price is $7.79 and its two-hundred day moving average price is $8.47. Daxor has a 52 week low of $6.55 and a 52 week high of $10.00.

Insider Buying and Selling

In other news, CEO Michael Richard Feldschuh acquired 3,360 shares of the stock in a transaction that occurred on Monday, March 10th. The shares were acquired at an average cost of $7.68 per share, for a total transaction of $25,804.80. Following the purchase, the chief executive officer now owns 210,852 shares of the company’s stock, valued at approximately $1,619,343.36. The trade was a 1.62 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 59.00% of the stock is owned by insiders.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Daxor stock. Keyes Stange & Wooten Wealth Management LLC lifted its holdings in shares of Daxor Co. (NASDAQ:DXR) by 34.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,612 shares of the company’s stock after purchasing an additional 3,771 shares during the quarter. Keyes Stange & Wooten Wealth Management LLC owned 0.30% of Daxor worth $126,000 at the end of the most recent quarter. 1.34% of the stock is owned by institutional investors.

Daxor Company Profile

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions.